Neurology Inpatient Clinical Education Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03826056|
Recruitment Status : Recruiting
First Posted : February 1, 2019
Last Update Posted : May 3, 2019
The objective of this study is to compare the effectiveness of a personalized patient education program to the current hospital education and evaluate its impact using patient satisfaction scores.
The investigators hypothesize that a personalized patient education intervention will increase patient's understanding of their diagnosis and satisfaction with the care as reflected in the survey results.
|Condition or disease||Intervention/treatment||Phase|
|Myasthenia Gravis Guillain-Barre Syndrome Multiple Sclerosis Seizures Parkinsonism Meningitis Encephalitis Headache Vestibular Disorder Spondylosis Normal Pressure Hydrocephalus||Behavioral: Current standard discharge educational intervention Behavioral: Personalized discharge educational intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||
Study team members will randomize patients to receive either the current standard hospital education material or the new personalized education material. Investigators will use a stratified randomization process to allocate the patients from different categories including age range, gender, and discharge diagnosis into each group. Thereby the investigators will achieve equal distribution of diagnoses and other demographics among groups in real time. They will review the two groups when performing statistical analysis near the end of the study to ensure heterogeneity of distribution.
A study team member who has also been a member of the care team will use the either the current hospital standard or the new personalized education materials to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.
|Masking Description:||The patient will not be informed of whether he or she is receiving the current hospital standard or the new personalized patient education intervention. The study team member will known which intervention is being used for patient education. The intervention arm will not be blinded in the data analysis.|
|Primary Purpose:||Health Services Research|
|Official Title:||Neurology Inpatient Clinical Education Trial|
|Actual Study Start Date :||February 1, 2019|
|Estimated Primary Completion Date :||October 31, 2019|
|Estimated Study Completion Date :||December 27, 2019|
Active Comparator: Current standard education group
A study team member will use the current hospital standard educational material to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.
Behavioral: Current standard discharge educational intervention
The patients will receive the current hospital standard discharge educational material which explains the diagnosis, new medications, follow up and any activity/diet restrictions. A member of the study team will explain this material to the patient and answer any questions.
Experimental: New personalized education group
A study team member will use the new personalized educational materials to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.
Behavioral: Personalized discharge educational intervention
The patients will receive a new personalized discharge educational material which will explain the specifics of their disorder, the treatment, and prognosis. The materials will contain simple, organized explanations and graphics. A member of the study team will explain this material to the patient and answer any questions.
- Patient satisfaction scores [ Time Frame: Subjects will be expected to mail the feedback forms within 2 weeks of discharge. Investigators will mail a single reminder prepaid return mail with a copy of the questionnaire to patients who do not respond within this time allowing 1 month total time. ]The patients will answer a survey consisting of seven multiple-choice questions regarding their perception of the education intervention. Each questions will be scored on a scale of one to four for a total possible score of 28 for all 7 questions. A score of 1 indicates a negative perception of the education whereas 4 indicates the most positive impression. Therefore the lowest possible score is 7 for a severely negative perception of the education and the highest score is 28 for a very positive impression of the education program. Only the total scores will be compared for statistical analysis. Scores from patients in the current standard and new personalized education intervention groups will be compared.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03826056
|Contact: Devin E Prior, MDfirstname.lastname@example.org|
|Contact: Kyrillos Eskander, MDemail@example.com|
|United States, New Hampshire|
|Dartmouth- Hitchcock Medical Center||Recruiting|
|Lebanon, New Hampshire, United States, 03756|
|Contact: Vijay Renga, MD 603-650-5104 firstname.lastname@example.org|
|Contact: Devin E Prior, MD 6036505104 email@example.com|
|Principal Investigator:||Vijay Renga, MD||Dartmouth-Hitchcock Medical Center|